Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Local cervical immunity in women with low-grade squamous intraepithelial lesions and immune responses after abrasion.

Ekalaksananan T, Malat P, Pientong C, Kongyingyoes B, Chumworathayi B, Kleebkaow P.

Asian Pac J Cancer Prev. 2014;15(10):4197-201.

2.

Comparative analysis of methods for collection and measurement of cytokines and immunoglobulins in cervical and vaginal secretions of HIV and HPV infected women.

Snowhite IV, Jones WE, Dumestre J, Dunlap K, Braly PS, Hagensee ME.

J Immunol Methods. 2002 May 1;263(1-2):85-95.

PMID:
12009206
3.

Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions.

Azar KK, Tani M, Yasuda H, Sakai A, Inoue M, Sasagawa T.

Hum Pathol. 2004 Nov;35(11):1376-84.

PMID:
15668895
4.

Prevalence of human papillomavirus genotypes, and mucosal IgA anti-viral responses in women with cervical ectopy.

Monroy OL, Aguilar C, Lizano M, Cruz-Talonia F, Cruz RM, Rocha-Zavaleta L.

J Clin Virol. 2010 Jan;47(1):43-8. doi: 10.1016/j.jcv.2009.10.008. Epub 2009 Nov 10.

PMID:
19906557
5.

Depressed type 1 cytokine synthesis by superantigen-activated CD4+ T cells of women with human papillomavirus-related high-grade squamous intraepithelial lesions.

Lee BN, Follen M, Shen DY, Malpica A, Adler-Storthz K, Shearer WT, Reuben JM.

Clin Diagn Lab Immunol. 2004 Mar;11(2):239-44.

6.

Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia.

Passmore JA, Milner M, Denny L, Sampson C, Marais DJ, Allan B, Gumbi PP, Hitzeroth II, Rybicki EP, Williamson AL.

Immunology. 2006 Dec;119(4):507-14. Epub 2006 Oct 9.

7.

Binding of human papillomavirus type 16 to heparan sulfate is inhibited by mucosal antibodies from patients with low-grade squamous intraepithelial lesions but not from cervical cancer patients.

Lopez TV, Cancio C, Cruz-Talonia F, Ruiz B, Sapp M, Rocha-Zavaleta L.

FEMS Immunol Med Microbiol. 2008 Nov;54(2):167-76. doi: 10.1111/j.1574-695X.2008.00484.x.

8.

Detection of antibodies against a human papillomavirus (HPV) type 16 peptide that differentiate high-risk from low-risk HPV-associated low-grade squamous intraepithelial lesions.

Rocha-Zavaleta L, Ambrosio JP, Mora-Garcia Mde L, Cruz-Talonia F, Hernandez-Montes J, Weiss-Steider B, Ortiz-Navarrete V, Monroy-Garcia A.

J Gen Virol. 2004 Sep;85(Pt 9):2643-50.

PMID:
15302958
9.

Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.

Molden T, Nygård JF, Kraus I, Karlsen F, Nygård M, Skare GB, Skomedal H, Thoresen SO, Hagmar B.

Int J Cancer. 2005 May 10;114(6):973-6.

10.

Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development.

Winer RL, Harris TG, Xi LF, Jansen KU, Hughes JP, Feng Q, Welebob C, Ho J, Lee SK, Carter JJ, Galloway DA, Kiviat NB, Koutsky LA.

J Med Virol. 2009 Apr;81(4):713-21. doi: 10.1002/jmv.21450.

11.

Characterization of Immunoglobulin A/G Responses During 3 Doses of the Human Papillomavirus-16/18 ASO4-Adjuvanted Vaccine.

Gonçalves AK, Giraldo PC, Farias KJ, Machado PR, Costa AP, de Souza LC, Crispim JC, Eleutério J Jr, Witkin SS.

Sex Transm Dis. 2016 May;43(5):335-9. doi: 10.1097/OLQ.0000000000000429.

PMID:
27100772
12.
13.
14.

Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA.

Perez Castro S, Iñarrea Fernández A, Lamas González MJ, Sarán Diez MT, Cid Lama A, Alvarez Martín MJ, Pato Mosquera M, López-Miragaya I, Estévez N, Torres Piñón J, Oña Navarro M.

J Med Virol. 2013 Jun;85(6):1063-8. doi: 10.1002/jmv.23544.

PMID:
23588733
15.

Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.

Hu T, Yang P, Zhu H, Chen X, Xie X, Yang M, Liu S, Wang H.

Diagn Pathol. 2015 Apr 2;10:20. doi: 10.1186/s13000-015-0254-8.

16.

Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV.

Passmore JA, Burch VC, Shephard EG, Marais DJ, Allan B, Kay P, Rose RC, Williamson AL.

J Med Virol. 2002 Jun;67(2):234-40.

PMID:
11992584
17.

Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study.

Velentzis LS, Sitas F, O'Connell DL, Darlington-Brown J, Egger S, Sinha R, Banks E, Frazer IH, Canfell K.

BMC Infect Dis. 2014 Dec 21;14:3861. doi: 10.1186/s12879-014-0676-z.

18.

The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.

Guo M, Gong Y, Wang J, Dawlett M, Patel S, Liu P, Bevers TB, Sneige N.

Cancer Cytopathol. 2013 Feb;121(2):79-85. doi: 10.1002/cncy.21240. Epub 2012 Dec 5.

19.

Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.

Tezcan S, Ozgur D, Ulger M, Aslan G, Gurses I, Serin MS, Giray BG, Dilek S, Emekdas G.

Asian Pac J Cancer Prev. 2014;15(9):3997-4003.

20.

Local applications of GM-CSF induce the recruitment of immune cells in cervical low-grade squamous intraepithelial lesions.

Hubert P, Doyen J, Capelle X, Arafa M, Renoux V, Bisig B, Seidel L, Evrard B, Bousarghin L, Gerday C, Boniver J, Foidart JM, Delvenne P, Jacobs N.

Am J Reprod Immunol. 2010 Aug 1;64(2):126-36. doi: 10.1111/j.1600-0897.2010.00834.x. Epub 2010 Mar 29.

Supplemental Content

Support Center